中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

10 records (took 0.018 seconds)

    RESONANCE MOTOR DIRECT DRIVE FLAPPING WING MICRO AIR VEHICLE SYSTEM
    5.
    发明申请
    RESONANCE MOTOR DIRECT DRIVE FLAPPING WING MICRO AIR VEHICLE SYSTEM 审中-公开
    谐振电机直接驱动飞行微型空中车辆系统

    公开(公告)号：US20160159477A1

    公开(公告)日：2016-06-09

    申请号：US14707877

    申请日：2015-05-08

    Applicant: PURDUE RESEARCH FOUNDATION

    Inventor： Xinyan Deng ,  Jian Zhang

    IPC: B64C33/02

    CPC classification number: B64C33/02 ,  B64C2201/025

    Abstract: Presented herein are an actuation system and a flapping wing micro aerial vehicle system. In one embodiment, for energy efficiency and to achieve a resonant system, the flapping wing is directly driven using conventional DC motors coupled with torsion springs. Using a transmission gear, the motor is designed to operating at an efficient speed, but generates an overall reciprocal motion to the wing. Closed loop control is applied to achieve tracking of the desired wing motion kinematics, the frequency of which is tuned to match the resonant frequency of the system. We also show that wing kinematic control can be achieved by tracking trajectories with different amplitude and bias, therefore creating flight control forces and torques.

    Abstract translation: 这里提出的是致动系统和扑翼机微型飞行器系统。 在一个实施例中，为了能量效率并实现谐振系统，使用与扭转弹簧耦合的常规DC电动机直接驱动扑翼。 使用传动齿轮，电机被设计成以有效的速度运行，但是产生对机翼的整体往复运动。 应用闭环控制来实现期望的机翼运动运动学的跟踪，其频率被调谐以匹配系统的谐振频率。 我们还显示，可以通过跟踪具有不同幅度和偏差的轨迹来实现机翼运动控制，从而产生飞行控制力和转矩。

    Metabolite Biomarkers for the Detection of Esophageal Cancer Using NMR
    9.
    发明申请
    Metabolite Biomarkers for the Detection of Esophageal Cancer Using NMR 审中-公开
    使用NMR检测食管癌的代谢物生物标志物

    公开(公告)号：US20160363560A9

    公开(公告)日：2016-12-15

    申请号：US14167270

    申请日：2014-01-29

    Applicant: Purdue Research Foundation

    Inventor： M. Daniel Raftery ,  Jian Zhang ,  Zane Hammoud

    IPC: G01N27/74

    CPC classification number: G01N27/74 ,  G01N33/57488 ,  G01N2570/00

    Abstract: Methods for the detection and screening of esophageal adenocarcinoma (EAC) patients and for the monitoring of EAC treatment using a panel or panels of small molecule metabolite biomarkers are disclosed. In other aspects, methods for detection and screening for the progression of high-risk conditions (BE and HGD) to EAC and to monitoring treatment using a panel or panels of small molecule metabolite biomarkers are disclosed. The biomarkers are sensitive and specific for the detection of EAC, and can also be used to classify Barrett's esophagus (BE) and high-grade dysplasia (HGD), which are widely regarded as precursors of EAC.

    Abstract translation: 公开了使用小分子代谢物生物标志物的小组或小组检测和筛选食管腺癌（EAC）患者和用于监测EAC治疗的方法。 在其他方面，公开了用于检测和筛选高危条件（BE和HGD）进展到EAC以及使用小分子代谢物生物标志物的小组或小组进行监测的方法。 生物标志物对EAC的检测敏感且特异，也可用于对Barrett食管（BE）和高度发育异常（HGD）进行分类，被广泛认为是EAC的前体。

    Metabolite Biomarkers for the Detection of Esophageal Cancer Using NMR
    10.
    发明申请
    Metabolite Biomarkers for the Detection of Esophageal Cancer Using NMR 审中-公开
    使用NMR检测食管癌的代谢物生物标志物

    公开(公告)号：US20140148349A1

    公开(公告)日：2014-05-29

    申请号：US14167270

    申请日：2014-01-29

    Applicant: Purdue Research Foundation

    Inventor： M. Daniel Raftery ,  Jian Zhang ,  Zane Hammoud

    IPC: G01N27/74

    CPC classification number: G01N27/74 ,  G01N33/57488 ,  G01N2570/00

    Abstract: Methods for the detection and screening of esophageal adenocarcinoma (EAC) patients and for the monitoring of EAC treatment using a panel or panels of small molecule metabolite biomarkers are disclosed. In other aspects, methods for detection and screening for the progression of high-risk conditions (BE and HGD) to EAC and to monitoring treatment using a panel or panels of small molecule metabolite biomarkers are disclosed. The biomarkers are sensitive and specific for the detection of EAC, and can also be used to classify Barrett's esophagus (BE) and high-grade dysplasia (HGD), which are widely regarded as precursors of EAC.

    Abstract translation: 公开了使用小分子代谢物生物标志物的小组或小组检测和筛选食管腺癌（EAC）患者和用于监测EAC治疗的方法。 在其他方面，公开了用于检测和筛选高危条件（BE和HGD）进展到EAC以及使用小分子代谢物生物标志物的小组或小组进行监测的方法。 生物标志物对EAC的检测敏感且特异，也可用于对Barrett食管（BE）和高度发育异常（HGD）进行分类，被广泛认为是EAC的前体。

Patent Agency Ranking